Market Research Reports and Industry Reports

European Enzyme Immunoassay(EIA) MARKET By Type, By Technique, By End User (Hospital Laboratories, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Reference Laboratories, Academics, Blood Banks) Analysis and Forecast to 2020

  • DESCRIPTION
  • TABLE OF
    CONTENTS
  • RELATED
    REPORTS
  • SAMPLE REQUEST
  • PURCHASE BY
    SECTION

The report analyzes the European enzyme immunoassay (EIA) Market by type, technique, end-user, and by country. The European enzyme immunoassay (EIA) market has been classified on the basis of types which mainly includes; EIA reagents & kits, and EIA analyzers. On the basis of technique the market is divided into; ELISA, rapid tests, and ELISPOT.
 
 Germany is the largest contributor to the European enzyme immunoassay (EIA) market, basically due to the rising incidences of chronic and infectious diseases, expanding pharmaceutical and biotechnology industries, and growing use of EIA in oncology. Germany is followed by U.K., and France.
 
 Enzyme immunoassays are widely used in the diagnosis of and research of HIV/AIDS and cancer, owing to which the increasing prevalence of HIV/AIDS and cancer in Europe will drive market growth in the region. According to WHO, the number of HIV patients in Europe increased from ~120,000 in 2011 to ~180,000 in 2012.
  Furthermore, according to the International Agency for Research on Cancer (IARC), approximately 3.45 million new cancer cases (excluding non-melanoma skin cancer) were reported in Europe in 2012; the prevalence is expected to grow further in the coming years.
 
 In-depth Market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, Annual reports and interviews with industry experts, key opinion leaders such as CEOs, directors, and marketing executives. In addition, the report also profiled key players of the market on various parameters such as business overview, financial overview, product portfolio, business strategies and recent developments of the respective company. Some of the key market players of the European enzyme immunoassay (EIA) market include Hoffmann-La Roche Ltd (Switzerland), Abbott (U.S.), bioMérieux SA (France), Siemens Healthcare GmbH (Germany), Alere (U.S.), BD (U.S.), Bio-Rad Laboratories, Inc. (U.S.) and others.

1 INTRODUCTION 11
 1.1 OBJECTIVES OF THE STUDY 11
 1.2 MARKET SEGMENTATION & COVERAGE 12
 1.3 STAKEHOLDERS 13
 2 RESEARCH METHODOLOGY 14
 2.1 INTEGRATED ECOSYSTEM OF THE ENZYME IMMUNOASSAY (EIA) MARKET 15
 2.2 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE 16
 2.2.1 TOP-DOWN APPROACH 17
 2.2.2 MACRO INDICATOR- BASED APPROACH 18
 2.3 ASSUMPTIONS 19
 3 EXECUTIVE SUMMARY 20
 4 MARKET OVERVIEW 22
 4.1 INTRODUCTION 22
 4.2 MARKET DRIVERS AND INHIBITORS 24
 5 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, TYPE/TECHNIQUE 26
 5.1 INTRODUCTION 27
 5.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE 27
 5.3 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE 29
 5.3.1 EUROPE ELISA MARKET, BY TYPE OF GENERATION 30
 5.3.2 EUROPE ELISA MARKET, BY PLATFORM 32
 6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER 34
 6.1 INTRODUCTION 35
 6.2 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 37
 6.3 EUROPE ELISA MARKET, BY END USER 38
 6.4 EUROPE RAPID TESTS MARKET, BY END USER 39
 6.5 EUROPE ELISPOT MARKET, BY END USER 40
 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY 41
 7.1 INTRODUCTION 42
 7.2 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET 42
 7.2.1 GERMANY ENZYME IMMUNOASSAY MARKET, BY TYPE 42
 7.2.2 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE 43
 7.2.2.1 GERMANY ELISA MARKET,BY TYPEOF GENERATION 43
 7.2.2.2 GERMANY ELISA MARKET,BY PLATFORM 43
 7.2.3 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 44
 7.2.3.1 GERMANY ELISA MARKET, BY END USER 44
 7.2.3.2 GERMANY RAPID TEST MARKET, BY END USER 45
 7.2.3.3 GERMANY ELISPOT MARKET, BY END USER 45
 7.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET 46
 7.3.1 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE 46
 7.3.2 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE 47
 7.3.2.1 U.K. ELISA MARKET,BY TYPEOF GENERATION 47
 7.3.2.2 U.K. ELISA MARKET,BY PLATFORM 47
 7.3.3 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 48
 7.3.3.1 U.K. ELISA MARKET, BY END USER 48
 7.3.3.2 U.K. RAPID TEST MARKET, BY END USER 49
 7.3.3.3 U.K. ELISPOT MARKET, BY END USER 49
 7.4 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET 50
 7.4.1 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE 50
 7.4.2 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE 51
 7.4.2.1 FRANCE ELISA MARKET,BY TYPE OF GENERATION 51
 7.4.2.2 FRANCE ELISA MARKET,BY PLATFORM 51
 7.4.3 FRANCE ENZYME IMMUNOASSAY MARKET, BY END USER 52
 7.4.3.1 FRANCE ELISA MARKET, BY END USER 52
 7.4.3.2 FRANCE RAPID TEST MARKET, BY END USER 53
 7.4.3.3 FRANCE ELISPOT MARKET, BY END USER 53
 7.5 ITALY ENZYME IMMUNOASSAY (EIA) MARKET 54
 7.5.1 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE 54
 7.5.2 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE 55
 7.5.2.1 ITALY ELISA MARKET, BY TYPE OF GENERATION 55
 7.5.2.2 ITALY ELISA MARKET, BY PLATFORM 55
 7.5.3 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER 56
 7.5.3.1 ITALY ELISA MARKET, BY END USER 56
 7.5.3.2 ITALY RAPID TESTS MARKET, BY END USER 57
 7.5.3.3 ITALY ELISPOT TESTS MARKET, BY END USER 57
 7.6 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET 58
 7.6.1 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE 58
 7.6.2 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE 59
 7.6.2.1 BENELUX ELISA MARKET, BY TYPEOF GENERATION 59
 7.6.2.2 BENELUX ELISA MARKET, BY PLATFORM 59
 7.6.3 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 60
 7.6.3.1 BENELUX ELISA MARKET, BY END USER 60
 7.6.3.2 BENELUX RAPID TESTS MARKET, BY END USER 61
 7.6.3.3 BENELUX ELISPOT TESTS MARKET, BY END USER 61
 7.7 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET 62
 7.7.1 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE 62
 7.7.2 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE 63
 7.7.2.1 SCANDANAVIA ELISA MARKET, BY TYPEOF GENERATION 63
 7.7.2.2 SCANDANAVIA ELISA MARKET, BY PLATFORM 63
 7.7.3 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 64
 7.7.3.1 SCANDANAVIA ELISA MARKET, BY END USER 64
 7.7.3.2 SCANDANAVIA RAPID TESTS MARKET, BY END USER 65
 7.7.3.3 SCANDANAVIA ELISPOT TESTS MARKET, BY END USER 65
 7.8 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET 66
 7.8.1 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE 66
 7.8.2 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE 67
 7.8.2.1 SPAIN ELISA MARKET, BY TYPEOF GNERATION 67
 7.8.2.2 SPAIN ELISA MARKET, BY PLATFORM 67
 7.8.3 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER 68
 7.8.3.1 SPAIN ELISA MARKET, BY END USER 68
 7.8.3.2 SPAIN RAPID TESTS MARKET, BY END USER 69
 7.8.3.3 SPAIN ELISPOT TESTS MARKET, BY END USER 69
 8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPETITIVE LANDSCAPE 70
 8.1 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS 70
 9 EUROPE ENZYME IMMUNO ASSAY (EIA) MARKET, BY COMPANY 72
 (Overview, Financials, Products & Services, Strategy, and Developments)*
 9.1 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.) 72
 9.2 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG) 75
 9.3 ABBOTT LABORATORIES, INC. 77
 9.4 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) 80
 9.5 ORTHO-CLINICAL DIAGNOSTICS, INC. 83
 9.6 BECTON, DICKINSON AND COMPANY 85
 9.7 BIOMÉRIEUX SA 87
 9.8 BIO-RAD LABORATORIES, INC. 89
 9.9 ALERE, INC. 92
 9.10 SYSMEX CORPORATION 96
 9.11 DIASORIN S.P.A. 98
 *Details on overview, financials, product & services, strategy, and developments might not be captured in case of unlisted company
 
 10 APPENDIX 100
 10.1 CUSTOMIZATION OPTIONS 100
 10.1.1 PRODUCT ANALYSIS 100
 10.1.2 BRAND/PRODUCT PERCEPTION MATRIX 100
 10.1.3 PORTER’S FIVE FORCES ANALYSIS 100
 10.2 RT SNAPSHOT 101
 10.3 RELATED REPORTS 102


List Of Tables

TABLE 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MN)
 TABLE 2 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MN)
 TABLE 3 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER ,
 2013-2020 (USD MN)
 TABLE 4 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET, BY COUNTRY,
 2013-2020 (USD MN)
 TABLE 5 ENZYME IMMUNOASSAY (EIA) MARKET: DRIVERS AND INHIBITORS
 TABLE 6 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECNIQUES,
 2013–2020 (USD MILLION)
 TABLE 8 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY TYPE OF GENERATION,
 2013–2020 (USD MILLION)
 TABLE 9 EUROPE ENZYMEIMMUNOASSAY (EIA) MARKET, BY PLATFORM,
 2013–2020 (USD MILLION)
 TABLE 10 EUROPE ENZYME IMMUNOASSAY MARKET, BY END-USER, 2013-2020 (USD MILLION)
 TABLE 11 EUROPE ELISA MARKET, BY END-USER, 2013-2020 (USD MILLION)
 TABLE 12 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
 TABLE 13 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
 TABLE 14 GERMANY EIA MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 15 GERMANY ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE,
 2013-2020 (USD MILLION)
 TABLE 16 GERMANY ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
 TABLE 17 GERMANY ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
 TABLE 18 GERMANY EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 19 GERMANY ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 20 GERMANY RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 21 GERMANY ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 22 U.K. ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 23 U.K. ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
 TABLE 24 U.K. ELISA MARKET, BY TYPE OF GENERATION, 2013-2020 (USD MILLION)
 TABLE 25 U.K. ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
 TABLE 26 U.K. EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 27 U.K. ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 28 U.K. RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 29 U.K. ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 30 FRANCE ENZYME IMMUNOASSAY MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 31 FRANCE ENZYME IMMUNOASSAY MARKET, BY TECHNIQUE, 2013-2020 (USD MILLION)
 TABLE 32 FRANCE ELISA MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 33 FRANCE ELISA MARKET, BY PLATFORM, 2013-2020 (USD MILLION)
 TABLE 34 FRANCE EIA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 35 FRANCE ELISA MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 36 FRANCE RAPID TEST MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 37 FRANCE ELISPOT MARKET, BY END USER, 2013-2020 (USD MILLION)
 TABLE 38 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 39 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MILLION)
 TABLE 40 ITALY ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
 TABLE 41 ITALY ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
 TABLE 42 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER,
 2013–2020 (USD MILLION)
 TABLE 43 ITALY ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 44 ITALY RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 45 ITALY ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 46 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 47 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MILLION)
 TABLE 48 BENELUX ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
 TABLE 49 BENELUX ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
 TABLE 50 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER,
 2013–2020 (USD MILLION)
 TABLE 51 BENELUX ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 52 BENELUX RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 53 BENELUX ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 54 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE,
 2013-2020 (USD MILLION)
 TABLE 55 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MILLION)
 TABLE 56 SCANDANAVIA ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
 TABLE 57 SCANDANAVIA ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
 TABLE 58 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER,
 2013–2020 (USD MILLION)
 TABLE 59 SCANDANAVIA ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 60 SCANDANAVIA RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 61 SCANDANAVIA ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 62 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013-2020 (USD MILLION)
 TABLE 63 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013-2020 (USD MILLION)
 TABLE 64 SPAIN ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
 TABLE 65 SPAIN ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
 TABLE 66 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY END USER,
 2013–2020 (USD MILLION)
 TABLE 67 SPAIN ELISA MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 68 SPAIN RAPID TESTS MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 69 SPAIN ELISPOT MARKET, BY END USER, 2013–2020 (USD MILLION)
 TABLE 70 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS,
 2014 (%) 


List Of Figures

FIGURE 1 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SEGMENTATION & COVERAGE
 FIGURE 2 ENZYME IMMUNOASSAY (EIA) MARKET: INTEGRATED ECOSYSTEM
 FIGURE 3 ARRIVING AT THE ENZYME IMMUNOASSAY (EIA) MARKET SIZE
 FIGURE 4 TOP-DOWN APPROACH
 FIGURE 5 MACRO INDICATOR-BASED APPROACH
 FIGURE 6 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET SNAPSHOT
 FIGURE 7 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TYPE, 2013–2020 (USD MILLION)
 FIGURE 8 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY TECHNIQUE,
 2013–2020 (USD MILLION)
 FIGURE 9 EUROPE ELISA MARKET, BY TYPE OF GENERATION, 2013–2020 (USD MILLION)
 FIGURE 10 EUROPE ELISA MARKET, BY PLATFORM, 2013–2020 (USD MILLION)
 FIGURE 11 EUROPE ENZYME IMMUNOASSAY (EIA) MARKET, BY END-USER,
 2013–2020 (USD MILLION)
 FIGURE 12 EUROPE ELISA MARKET, BY END-USER, 2013–2020 (USD MILLION)
 FIGURE 13 EUROPE RAPID TESTS MARKET, BY END-USER, 2013–2020 (USD MILLION)
 FIGURE 14 EUROPE ELISPOT MARKET, BY END-USER, 2013–2020 (USD MILLION)
 FIGURE 15 GERMANY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 16 U.K. ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 17 FRANCE ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 18 ITALY ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 19 BENELUX ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 20 SCANDANAVIA ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 21 SPAIN ENZYME IMMUNOASSAY (EIA) MARKET, BY GEOGRAPHY, MARKET SNAPSHOT 2014 & 2020
 FIGURE 22 EUROPEAN ENZYME IMMUNOASSAY (EIA) MARKET: COMPANY SHARE ANALYSIS,
 2014 (%)
 FIGURE 23 ROCHE DIAGNOSTICS (A DIVISION OF F. HOFFMANN-LA ROCHE LTD.): REVEUE MIX, 2014 (%)
 FIGURE 24 SIEMENS HEALTHCARE (SUBSIDIARY OF SIEMENS AG) REVENUE MIX, 2014 (%)
 FIGURE 25 ABBOTT LABORATORIES, INC. REVENUE MIX, 2014 (%)
 FIGURE 26 BECKMAN COULTER (SUBSIDIARY OF DANAHER CORPORATION) REVENUE MIX,
 2013 (%)
 FIGURE 27 BECTON, DICKINSON AND COMPANY: REVENUE MIX 2014 (%)
 FIGURE 28 BIOMÉRIEUX SA: REVENUE MIX 2014 (%)
 FIGURE 29 BIO-RAD LABORATORIES, INC.: REVENUE MIX 2014 (%)
 FIGURE 30 SYSMEX CORPORATION BUSINESS SERVICES, LLC: REVENUE MIX 2014 (%)
 FIGURE 31 DIASORIN S.P.A: GEOGRAPHICAL AND BUSINESS REVENUE MIX 2014(%) 


Speciality European Pharma Limited Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Speciality European Pharma Limited Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

Pan European Terminals PLC Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

Pan European Terminals PLC Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current market conditions, SWOT

USD 200View Report

North European Oil Royalty Trust - 2015 Company Profile- Outlook, Business Segments, Competitors, Goods and Services, SWOT and Financial Analysis

North European Oil Royalty Trust - 2015 Company Profile is a complete analysis of the companys operations, strategies, outlook and historic performance. The research work analyzes key strategies in current

USD 200View Report

Fill The Form For Sample Request
Name*
Email*
Mobile No.*
LandLine No.
If you want to purchase particular section from this report then kindly contact us at contact@aarkstore.com.

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    $ 2650
  • Multi User Licence    $ 3250
  • Corporate Licence    $ 4505
  • Enterprise Wide Licence    $ 5150
$ 2650

Reports Details

Published Date : Oct 2015
No. of Pages :103
Country :Europe
Category :Healthcare
Publisher :Micro Market Monitor
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

payment